Richard A. Basile, Co Founder and CEO of BioPontis Alliance for Rare Diseases, discusses the state of rare diseases and the critical challenges facing it.
BioPontis is an international nonprofit organization whose mission is to advance promising science into potential treatments for rare neurological diseases. BioPontis Alliance for Rare Diseases is dedicated to the development of new therapeutic agents to treat rare diseases.
BioPontis uses a collaborative approach, partnering with patient organizations and academic researchers. The company provides the plans and executes the preclinical translational scientific, early clinical development, patenting, and business relationship management.
